| International Session（Symposium）8(JGES・JSGE・JSGS・JSGCS) |
| Sat. November 23rd 14:30 - 17:00 Room 11: Portopia Hotel South Wing Topaz |
| Current capsule endoscopy Pillcam SB3 accurately predicts rebleeding of OGIB | |||
| Tatsushi Naito1, Katsushi Hiramatsu1, Yasunari Nakamoto1 | |||
| 1Second Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui | |||
|
|||
|
|||
| Background: It remains elusive whether rebleeding of OGIB can be predicted by capsule endoscopy. In this study we clarified the diagnostic factor for rebleeding of OGIB by comparing former Pillcam SB1, SB2 and current Pillcam SB3. Methods: Among 86 OGIB patients who underwent capsule endoscopy, we enrolled 73 patients who were followed up without therapeutic intervention. Patients were divided into two groups, the early group (n = 35) in which Pillcam SB1, SB2 were used from April 2010 to September 2012 and the late group (n = 38) by Pillcam SB3 from October 2015 to March 2018. The initial capsule endoscopic findings in each group were evaluated by P0-P2 grading system (Saurin et al. Endoscopy 2003), and following rebleeding was evaluated. Results: Endoscopic findings in the early and the late group were as follows respectively, P0-1 (no or slight findings): 28 (80.0%) vs. 34 cases (89.5%), P2 (significant findings): 7 (20.0%) vs. 4 cases (10.5%). Rebleeding from cases with P0-1 findings was significantly fewer (5.9%, p < 0.01) in the late group compared to the early group (35.7%), while rebleeding from cases with P2 findings was frequent (50.0%). In rebleeding cases, angioectasia was often missed in the early group. Conclusions: P2 finding by current Pillcam SB3 accurately predicts rebleeding of OGIB. |
|||
|
Index Term 1: OGIB Index Term 2: capsule endoscopy |
|||
| Page Top | |||